Class II Medical Device Development Plan
Uploaded by
hairulanuarsuliClass II Medical Device Development Plan
Uploaded by
hairulanuarsuliCommon questions
Powered by AIThe design and development phases align with regulatory requirements by following a structured approach: starting with defining user needs and design inputs, ensuring outputs meet these needs through controlled development, and systematically verifying and validating these outputs. Each phase includes design reviews and documentation as mandated by standards like ISO 13485 and 21 CFR 820.30, ensuring each step meets quality and regulatory criteria .
Adherence to ISO 13485 ensures that the design and development process meets international quality management system requirements specific to medical devices. This compliance enhances product safety and reliability, facilitates regulatory approvals, and increases market access. ISO 13485 aligns with regulatory requirements such as 21 CFR 820.30, providing a framework for consistent quality and risk management practices across the lifecycle of the device .
Documenting design reviews, including meeting minutes and attendance records, provides a traceable record of decisions, actions, and accountability, essential for regulatory compliance and quality assurance. It ensures consistent communication and understanding among stakeholders and facilitates the resolution of issues identified during the reviews, contributing to a thorough and well-documented development history .
The DHF compilation is critical for documenting the design and development history, demonstrating compliance with regulatory standards such as ISO 13485 and 21 CFR 820.30. It serves as a comprehensive record of design inputs, outputs, verification, validation, and reviews, facilitating audits and providing a foundation for continuous improvement of design processes .
DFM consideration ensures that the design can be reliably and cost-effectively manufactured at the intended scale, simplifying the transition from design to production. It involves assessing materials, processes, and design complexity, reducing production risks and costs. By aligning design specifications with manufacturing capabilities early, it supports efficient production and regulatory compliance .
Design reviews serve to evaluate the progress and quality of design outputs at each phase, ensuring they meet project specifications and compliance requirements. These reviews involve cross-functional teams and are documented with minutes and attendance, facilitating transparency and accountability. They help identify issues early, preventing costly changes later in the development process .
The integration of risk management throughout the design process ensures that potential hazards are identified and mitigated early, aligning with ISO 14971 standards. It allows for proactive identification and management of risks, improving device safety and compliance. This approach also facilitates continuous monitoring and adjustment to address new risks as the project progresses .
The QA team is responsible for compliance oversight and conducting design reviews. They ensure design outputs meet the necessary regulatory standards and support overall design integrity. Continuous oversight by the QA team helps maintain compliance with ISO 13485 and 21 CFR 820.30, ensuring all design activities adhere to established quality standards .
The R&D Lead, as the Design Control Owner, is responsible for overseeing the design process, ensuring adherence to design controls and regulatory standards. They coordinate the development of design inputs and outputs, facilitate cross-functional collaboration, and manage the integration of risk management strategies. This role is crucial in aligning design activities with project objectives and compliance requirements .
Regulatory inputs ensure the design phase addresses all necessary compliance aspects, aligning with requirements such as those set by ISO 13485 and 21 CFR 820.30. Submission alignment ensures that all regulatory documentation and validations are ready for approval processes. This approach mitigates delays, facilitates smoother approval pathways, and ensures the product can be legally marketed .